a public good project by the
Synthesis
Company
of California

© 2026

Rapid Detection of the DPYD IVS14+1G>A Mutation for Screening Patients to Prevent Fluorouracil-Related Toxicity | doi.page

0 citations0 references

Google Scholar doi.org

Rapid Detection of the DPYD IVS14+1G>A Mutation for Screening Patients to Prevent Fluorouracil-Related Toxicity

Molecular Diagnosis & Therapy·2007·Vol. 11(2), pp. 105–108

Citations Over Time

Tessa M. Bosch, Remko Bakker, Jan H.M. Schellens, Annemieke Cats, Paul H.M. Smits, Jos H. Beijnen

Related Papers

→ Capecitabine‐based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiency(2017)27 cited
→ Identifying a Novel DPYD Polymorphism Associated with Severe Toxicity to 5‐FU Chemotherapy in a Saudi Patient(2019)11 cited
[Prevention of severe toxicity from capecitabine, 5-fluorouracil and tegafur by screening for DPD-deficiency].(2012)
→ Fluoropyrimidine-Induced Severe Toxicities Associated with Rare DPYD Polymorphisms: Case Series from Saudi Arabia and a Review of the Literature(2021)8 cited